Apeloa Pharmaceutical Co.,Ltd

Symbol: 000739.SZ

SHZ

14.01

CNY

Markedspris i dag

15.0522
P/E-forhold
0.3216
PEG Ratio
16.38B
MRK Cap
0.02%
DIV Udbytte

Apeloa Pharmaceutical Co.,Ltd (000739-SZ) Årsregnskaber

Q: Hvad er virksomhedens profitmargin?

Virksomhedens profitmargin er .

Download

Årlig Kvartalsvis

Lineær Log

På diagrammet kan du se standardtallene i dynamik for Apeloa Pharmaceutical Co.,Ltd (000739.SZ). Virksomhedens omsætning viser gennemsnittet af 3072.75 M, som er 0.225 % gowth. Den gennemsnitlige bruttofortjeneste for hele perioden er 793.225 M, som er 0.491 %. Den gennemsnitlige bruttofortjeneste er 0.211 %. Væksten i nettoindkomst for virksomheden sidste år er 0.067 %, hvilket svarer til 0.341 % % i gennemsnit for hele virksomhedens historie.,

Årlig Kvartalsvis

10Y 20Y 30Y 40Y

Balance

Når vi dykker ned i den skattemæssige udvikling for Apeloa Pharmaceutical Co.,Ltd, ser vi en gennemsnitlig aktivvækst. Det er interessant, at denne rate ligger på , hvilket afspejler både virksomhedens op- og nedture. Når man sammenligner kvartal for kvartal, justeres dette tal til 0. Et kig tilbage på det seneste år afslører en samlet aktivændring på 0.063. Når det gælder omsætningsaktiver, er 000739.SZ på 8368.16 i rapporteringsvalutaen. En betydelig del af disse aktiver, helt præcist 3580.687, ligger i kontanter og kortfristede investeringer. Dette segment viser en ændring på 0.008%, når det sammenlignes med sidste års data. Virksomhedens langsigtede investeringer, som ikke er dens fokus, ligger på 174.047, hvis nogen, i rapporteringsvalutaen. Dette indikerer en forskel på 90.595% fra den sidste rapporteringsperiode, hvilket afspejler virksomhedens strategiske skift. Virksomhedens gældsprofil viser en samlet langfristet gæld på 18.694 i rapporteringsvalutaen. Dette tal betyder en ændring fra år til år på 3.093%. Aktionærværdi, som vist ved den samlede egenkapital, er vurderet til 6222.729 i rapporteringsvalutaen. Ændringen fra år til år i dette aspekt er 0.129%. Et dybere dyk ned i virksomhedens økonomi afslører yderligere detaljer. Nettotilgodehavenderne er vurderet til 2420.562, med en værdiansættelse af varelageret på 2083.3 og goodwill vurderet til 20.31, hvis der er nogen. De samlede immaterielle aktiver, hvis de findes, værdiansættes til 319.8.

common:word.in-mln USD Growth	TTM	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002	2000	1998	1996	1994
balance-sheet.row.cash-and-short-term-investments	14812.83	3580.7	3552.9	2624.9	2310.4	1499.7	644	551.2	553	795.1	809.6	812.7	833.4	253.8	279.5	248.3	280.1	502.3	247.8	137.9	220.7	131.6	30.4	17.3	13.6	73.4	23.1	7.8	5	5.5	5.9
balance-sheet.row.short-term-investments	-65.1	0	0.1	14.9	116.2	463.9	-7.2	4.2	-3.7	-4.1	1.9	2	1.9	1.7	2.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.net-receivables	10834.01	2420.6	2286.8	1804.6	1455	1377.5	1367.7	1488.4	1301.7	863.2	882	979.4	779.4	316.3	267	297.6	223.5	232.5	228.9	200.7	170.3	164.2	129.3	96.7	10.6	5.1	3.8	4.9	14.9	8.2	13.4
balance-sheet.row.inventory	7885.31	2083.3	1801.8	1249.9	1086.2	993	901	727.2	693.5	722.3	585.1	632.3	477.7	301.9	259.3	220.1	257.7	195.7	180.6	165.6	158.5	126.4	119.2	63.1	99.7	106.4	121.3	30	27.3	22.4	42.3
balance-sheet.row.other-current-assets	546.48	283.6	139.6	102.5	65.7	87.7	161.8	103.5	93.6	85.2	58.5	-40.1	-18.2	-2.8	-2.8	-9.6	-5.2	-4.8	-3.4	-5.4	-8.7	-9	-16	-14.8	70.3	80.2	67	26.8	-2.8	4.2	7.1
balance-sheet.row.total-current-assets	34078.64	8368.2	7781.1	5781.9	4917.4	3958	3074.5	2870.2	2641.8	2465.8	2335.2	2384.4	2072.2	869.1	803.1	756.5	756.1	925.8	653.9	498.8	540.7	413.2	262.9	162.4	194.2	265.1	215.1	69.6	44.5	40.3	68.6
balance-sheet.row.property-plant-equipment-net	14152.56	3617.4	3405.9	2682.9	1981.2	2017.8	2123.3	2286.8	2340.2	2306	2139.4	1758.9	1555.1	907	816.9	765.5	749.7	553.5	603.9	609.6	533	347.7	324.4	317.5	243.4	240.6	242.7	234.4	119.9	106	72.8
balance-sheet.row.goodwill	81.24	20.3	20.3	20.3	20.3	20.3	29.5	29.5	29.5	29.5	29.5	20.3	20.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.intangible-assets	1284.29	319.8	378.8	407.6	345.1	331.2	363.2	401.2	441.9	474.5	478.8	470.3	431.5	275.1	217.7	222.9	230.5	131.4	3.4	5.6	8	10.4	2.7	2.2	7.6	8.1	1.9	0	0	0	0
balance-sheet.row.goodwill-and-intangible-assets	1365.53	340.1	399.1	427.9	365.4	351.5	392.7	430.7	471.4	504	508.3	490.6	451.8	275.1	217.7	222.9	230.5	131.4	3.4	5.6	8	10.4	2.7	2.2	7.6	8.1	1.9	0	0	0	0
balance-sheet.row.long-term-investments	715.76	174	91.3	66.4	5.5	-341.6	108.1	31.8	35.7	33.7	-1.4	-1.5	-1.4	-1.2	-1.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.tax-assets	955.25	247.4	265.6	47.6	39.6	49	40.7	55.4	67	59.4	41.2	27.7	27.3	9.9	6.4	4.8	4.8	3.5	3.6	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.other-non-current-assets	270.73	20.6	73.6	156.6	185.6	487.9	11.4	16.2	62.9	26.1	39.1	2.2	2.1	1.7	2.3	0	0	0	19.7	30.9	32.7	91.9	99.2	105.3	101.4	6.6	15.4	13.3	0	0	0.1
balance-sheet.row.total-non-current-assets	17459.84	4399.5	4235.5	3381.4	2577.4	2564.6	2676.2	2820.9	2977.2	2929.2	2726.6	2277.9	2035	1192.6	1041.5	993.2	985	688.4	630.6	646	573.7	449.9	426.4	425	352.4	255.3	260.1	247.7	119.9	106	72.9
balance-sheet.row.other-assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-assets	51538.48	12767.7	12016.6	9163.3	7494.8	6522.6	5750.8	5691.1	5619	5394.9	5061.8	4662.3	4107.2	2061.8	1844.6	1749.7	1741.1	1614.1	1284.4	1144.9	1114.5	863.1	689.3	587.4	546.6	520.3	475.2	317.2	164.4	146.3	141.5
balance-sheet.row.account-payables	15550.44	2013.9	4310.6	2622.5	1928.7	2010.3	1113.3	933.9	1151.9	1333	1339.6	1109.7	1168.2	510.2	405	407.9	335.2	322.5	225.2	158	174.2	130.6	77.1	70.7	36.7	40.2	39.3	32.6	48.8	38.4	29.6
balance-sheet.row.short-term-debt	5990.9	3403.5	571.9	346.4	330.3	50	614.1	1088	1116.1	1033.1	758.8	1205.9	1242.6	551.5	495.7	420.2	470.2	369.2	383.1	333.2	352.2	203.2	264.7	154.2	117	86	34	20	6	18.2	21.1
balance-sheet.row.tax-payables	383.56	77	117.6	190.7	227.7	83.3	87.3	101	99.6	64.5	71.7	47	57.1	14.3	8.4	10.5	8.1	7.6	16.5	10.4	5.5	9.4	7	6.9	2.5	5.1	13.2	5.2	7.1	10	3.4
balance-sheet.row.long-term-debt-total	267.11	18.7	265.4	127.9	0	72	72	72	180	196.6	172	167	37.5	38.5	0	0	60	90	130	140	140	110	0	40	0	0	0	0	30	17.2	34.3
Deferred Revenue Non Current	132.38	30.6	15.1	119.8	125.4	119.8	130.1	129.8	100.9	98.7	95.4	83.6	0.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.deferred-tax-liabilities-non-current	418.6	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.other-current-liab	1435.26	460	685.9	18	5.8	140.5	388.9	75.1	77.3	53.6	70.8	80.7	34.9	27	17.6	13.6	29.4	28.2	22.6	15.9	9.8	6.1	5.2	3.7	54.3	58.5	77.2	1.2	0.5	0.5	0.2
balance-sheet.row.total-non-current-liabilities	1079.97	198.9	470.8	324	207.7	193	202.8	203.7	353.7	296.3	268.4	242.8	111.5	76.4	16.4	18.7	65.4	93.8	130	140	145.4	122.3	0	40	3.6	3.2	2.3	1.4	30.6	17.5	34.5
balance-sheet.row.other-liabilities	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.capital-lease-obligations	32.69	4.5	15.8	22.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-liab	27012.14	6506.6	6497.4	4103.3	3104.1	2754.6	2406.5	2641.1	3002.5	2978.1	2755.9	2804.4	2741.6	1255.1	1036	954.9	973	864	828.7	732.9	743.4	534.2	402.9	327.7	231.5	212.4	227.2	95.8	114.2	98.5	106.2
balance-sheet.row.preferred-stock	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.common-stock	4714.09	1178.5	1178.5	1178.5	1178.5	1178.5	1178.5	1178.5	1146.9	1146.9	1146.9	815.5	374.5	256.7	256.7	256.7	256.7	256.7	145.7	145.7	145.7	145.7	145.7	145.7	145.7	145.7	75.6	63	32.6	18.4	18.4
balance-sheet.row.retained-earnings	17750.62	4520	3854.5	3240.1	2608.8	2018.8	1619.6	1340.1	1172.9	981.8	876.8	575.1	408.9	164.4	161.3	143.2	114.5	86.8	111.4	76.9	54.8	37.2	14.2	-66.4	-5.3	-10.9	20.6	0.7	0	15.5	5.6
balance-sheet.row.accumulated-other-comprehensive-income-loss	1206.9	288.3	243	205.3	167.3	134.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.other-total-stockholders-equity	793.7	235.9	235.9	436.1	436.1	436.1	546.2	531.4	296.7	288.1	282.3	401.8	567.8	372.3	372.3	371.7	371.4	370.1	159.8	149.7	133.4	122.6	111.4	167.7	173.2	171.4	151	157.8	17.5	13.9	11.3
balance-sheet.row.total-stockholders-equity	24465.32	6222.7	5511.9	5060	4390.7	3768	3344.3	3050	2616.5	2416.7	2305.9	1792.3	1351.1	793.4	790.3	771.6	742.7	713.6	417	372.3	334	305.6	271.4	247.1	313.7	306.2	247.2	221.5	50.1	47.8	35.3
balance-sheet.row.total-liabilities-and-stockholders-equity	51538.48	12767.7	12016.6	9163.3	7494.8	6522.6	5750.8	5691.1	5619	5394.9	5061.8	4662.3	4107.2	2061.8	1844.6	1749.7	1741.1	1614.1	1284.4	1144.9	1114.5	863.1	689.3	587.4	546.6	520.3	475.2	317.2	164.4	146.3	141.5
balance-sheet.row.minority-interest	30.39	7.7	7.3	0	0	0	0	0	0	0.1	0	65.5	14.4	13.3	18.3	23.2	25.4	36.5	38.8	39.6	37.1	23.3	15	12.6	1.4	1.7	0.8	0	0	0	0
balance-sheet.row.total-equity	24495.71	6230.4	5519.2	5060	4390.7	3768	3344.3	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.total-liabilities-and-total-equity	51538.48	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Investments	650.66	174	91.4	81.2	121.7	122.2	100.9	36	32	29.6	0.5	0.5	0.5	0.5	0.5	0	0	0	23.3	27.3	31.2	91.7	99.2	105.2	99	4.9	13.3	0	0	0	0
balance-sheet.row.total-debt	6262.49	3426.7	837.3	474.3	330.3	50	614.1	1088	1296.1	1229.8	930.8	1372.9	1280.1	590	495.7	420.2	530.2	459.2	513.1	473.2	492.2	313.2	264.7	194.2	117	86	34	20	36	35.4	55.4
balance-sheet.row.net-debt	-8550.35	-154	-2715.6	-2135.7	-1864	-985.8	-29.9	541	743.1	434.7	123	562.2	448.6	338	218.5	171.9	250.1	-43.1	265.2	335.3	271.5	181.6	234.3	176.9	103.4	12.6	10.9	12.2	31	29.9	49.5

Pengestrømsopgørelse

Det økonomiske landskab for Apeloa Pharmaceutical Co.,Ltd har set en bemærkelsesværdig ændring i det frie cash flow i løbet af den sidste periode, hvilket udviser et skift på -0.509. Virksomheden udvidede for nylig sin aktiekapital ved at udstede 0, hvilket markerer en forskel på 0.000 i forhold til det foregående år. Det er interessant, at en del af virksomhedens aktier, nemlig 0, blev købt tilbage af virksomheden selv. Denne handling resulterede i en ændring på 0.000 fra det foregående år. I mellemtiden er virksomhedens leverandørgæld i øjeblikket på 130.17 i rapporteringsvalutaen. Virksomhedens investeringsaktiviteter resulterede i et nettokasseforbrug på -676422944.000 i rapporteringsvalutaen. Dette er en forskydning på 0.144 fra året før. I samme periode har virksomheden registreret 558.97, 0 og -96.52, som er væsentlige for forståelsen af virksomhedens investerings- og afdragsstrategier. Virksomhedens finansieringsaktiviteter førte til et nettokasseforbrug på 0.000, med en forskel fra år til år på 0.000. Desuden afsatte virksomheden -347.29 til udbetaling af udbytte til sine aktionærer. Samtidig foretog virksomheden andre finansielle manøvrer, kaldet 141.95, som også påvirkede pengestrømmen betydeligt i denne periode. Disse komponenter tegner tilsammen et omfattende billede af virksomhedens økonomiske status og strategiske tilgang til likviditetsstyring.

common:word.in-mln USD Growth	TTM	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002	2000	1998
cash-flows.row.net-income	1059.75	1055.3	989.2	955.6	816.7	553.4	370.6	256.6	262.9	208.2	326.7	161	134.6	3.2	20	32.9	26	27.8	51.1	46.1	37.5	36.7	34	-26	7.5	7.6	25.7
cash-flows.row.depreciation-and-amortization	-0.82	559	389.4	358.6	353.8	353.5	329.4	331.6	302	286.2	247.8	227.5	193.3	100.5	90.1	82.3	66.4	52.4	53.1	44.4	37.7	33.5	27.3	4.1	6.1	6.1	4.5
cash-flows.row.deferred-income-tax	0	3.6	-104	-14	18.4	-7.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.stock-based-compensation	0	-1932.7	104	14	-18.4	7.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.change-in-working-capital	-908.1	-777.9	-165.8	-682.1	-74.1	360.7	40.7	-482.6	-433.5	-144.8	193	-293.4	-84.6	44.2	-13.3	55.6	-39.9	57	7.7	-33.2	-49.3	13.7	-84.3	12.6	-1.5	-40.3	-2.4
cash-flows.row.account-receivables	-571.63	-571.6	-1108.1	-851.4	-176.8	-294.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.inventory	-373.35	-373.3	-603.1	-190.1	-116.9	-124.9	-207.5	-60.2	6	-168.8	29.4	-163.2	2.4	-43.1	-39.3	37	-69.8	-10.5	-15.2	-8	-22.2	-7.9	-56.1	22	13.4	-3.3	-15.8
cash-flows.row.account-payables	0	130.2	1649.3	373.4	201.1	787.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.other-working-capital	36.87	36.9	-104	-14	18.4	-7.8	248.2	-422.3	-439.5	24	163.6	-130.1	-87	87.3	26	18.6	29.9	67.5	22.9	-25.2	-27	21.5	-28.2	-9.4	-14.9	-37	13.4
cash-flows.row.other-non-cash-items	937.72	2124.1	113.3	-20.3	-36.9	92.4	92	104.2	49	91.5	19.2	95.3	92.7	33.8	24.2	37.5	42.1	37	47.5	30.1	21.6	21.5	25.8	8.7	-5.1	6	2.2
cash-flows.row.net-cash-provided-by-operating-activities	1088.54	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.investments-in-property-plant-an-equipment	-634.54	-630.5	-509.1	-701.9	-317.1	-31.8	-81.6	-163.4	-331.4	-452.1	-540.2	-505	-339.6	-289.2	-139.8	-93.7	-349	-115.7	-53.8	-121.7	-111.1	-88.1	-47.2	-1	-3.2	-7.8	-16.4
cash-flows.row.acquisitions-net	46.96	39.7	12.2	3.9	16.7	-1	16.3	246.7	14.5	11.8	22.9	-1.6	352	0	5	0	0	-4.3	0	0	1.9	0	0	0	3.2	7.8	0
cash-flows.row.purchases-of-investments	-161.37	-172.9	-389	-446.9	-424.5	-864	-356.5	-196.9	-34	-48.5	34.9	-8.4	-0.5	0	-52.8	0	0	0	0	0	-28.2	0	0	0	-92.9	-3	0
cash-flows.row.sales-maturities-of-investments	87.26	87.3	383.2	559.1	821.8	516.9	257.1	197.6	34.2	47.8	11	1	0.6	0	50	0	0	0	0	0	61.1	0	0	6.3	4.2	11.4	0
cash-flows.row.other-investing-activites	-8.73	0	-88.6	70.5	9.5	-60.9	-14.3	-163.4	16.9	0	-0.2	9.9	-339.6	28.3	1.1	1	1.2	4.1	1.7	4.4	11.9	35.4	11.6	8.1	-3.2	-7.8	0
cash-flows.row.net-cash-used-for-investing-activites	-670.42	-676.4	-591.3	-515.4	106.4	-440.8	-179	-79.4	-299.8	-441	-471.6	-504.1	-327.1	-261	-136.5	-92.7	-347.9	-116	-52.1	-117.3	-64.4	-52.7	-35.6	13.4	-91.9	0.6	-16.4
cash-flows.row.debt-repayment	-814.12	-96.5	-712.7	-698.2	-204	-944.1	-1639	-1675.5	-1454.8	-1081.4	-1880.5	-1368.8	-1901.1	-675	-634.6	-500	-281	-391.9	-101	-59	-290.5	-271	-199.6	-75.8	-79.8	-38.2	-13
cash-flows.row.common-stock-issued	0	0	200.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.common-stock-repurchased	0	0	-200.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.dividends-paid	-386.19	-347.3	-362.8	-301.9	-201.4	-142.1	-119.8	-141.6	-129.4	-162.5	-88.2	-75.4	-84.7	-40.2	-31.2	-37.4	-39.9	-44.7	-39.4	-30.6	-24.5	-18.3	-24.6	-10.3	-6	-1.8	-12.4
cash-flows.row.other-financing-activites	913.9	141.9	879.4	795.8	484.1	380	1165.1	1724.6	1631.5	1286.6	1644.8	1821.4	2031.8	769.3	710.1	390	352	632.8	143	36.7	421.1	337.8	270.1	77	110.9	110.2	27
cash-flows.row.net-cash-used-provided-by-financing-activities	-366.84	-301.9	-196.1	-204.3	78.7	-706.2	-593.7	-92.5	47.3	42.6	-323.8	377.2	46.1	54.1	44.3	-147.4	31.1	196.2	2.6	-52.9	106.1	48.5	45.9	-9.1	25	70.2	1.6
cash-flows.row.effect-of-forex-changes-on-cash	39.7	27.5	44	-17.3	-38.3	3.3	7.3	-14.4	18.4	10.1	-0.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.net-change-in-cash	-0.36	27.8	582.8	-125.3	1206.4	216.4	67.2	23.4	-53.6	52.9	-9.6	63.5	54.9	-25.2	28.9	-31.8	-222.2	254.5	109.9	-82.8	89.2	101.1	13.1	3.7	-59.8	50.3	15.3
cash-flows.row.cash-at-end-of-period	11369.38	3580.7	2381.9	1799.2	1924.4	718.1	501.4	434.1	410.7	464.4	411.5	421.1	357.5	252.1	277.2	248.3	280.1	502.3	247.8	137.9	220.7	131.6	30.4	17.3	13.6	73.4	23.1
cash-flows.row.cash-at-beginning-of-period	11369.75	3552.9	1799.2	1924.4	718.1	501.7	434.1	410.7	464.4	411.5	421.1	357.5	302.6	277.2	248.3	280.1	502.3	247.8	137.9	220.7	131.6	30.4	17.3	13.6	73.4	23.1	7.8
cash-flows.row.operating-cash-flow	1088.54	1031.4	1326.1	611.7	1059.5	1360.1	832.7	209.8	180.4	441.2	786.6	190.4	335.9	181.7	121	208.3	94.6	174.2	159.4	87.4	47.5	105.4	2.8	-0.6	7.1	-20.5	30.1
cash-flows.row.capital-expenditure	-634.54	-630.5	-509.1	-701.9	-317.1	-31.8	-81.6	-163.4	-331.4	-452.1	-540.2	-505	-339.6	-289.2	-139.8	-93.7	-349	-115.7	-53.8	-121.7	-111.1	-88.1	-47.2	-1	-3.2	-7.8	-16.4
cash-flows.row.free-cash-flow	454	400.9	817	-90.2	742.4	1328.2	751.1	46.4	-150.9	-10.9	246.4	-314.6	-3.7	-107.5	-18.8	114.6	-254.5	58.5	105.6	-34.3	-63.5	17.3	-44.4	-1.6	3.9	-28.3	13.7

Resultatopgørelse række

Apeloa Pharmaceutical Co.,Ltds omsætning oplevede en ændring på 0.083% sammenlignet med den foregående periode. Bruttofortjenesten for 000739.SZ rapporteres til at være 2731.52. Virksomhedens driftsomkostninger er 1649.39 og viser en ændring på 13.274% fra sidste år. Udgifterne til afskrivninger er 558.97, hvilket er en ændring på 0.020% fra sidste regnskabsperiode. Driftsudgifterne rapporteres at være 1649.39, hvilket viser en 13.274% ændring fra år til år. Salgs- og marketingomkostninger er 0, hvilket er en ændring på 0.000% sammenlignet med året før. EBITDA baseret på de seneste tal er 0, hvilket repræsenterer en 0.070% vækst i forhold til året før. Driftsindtægterne er 1082.12, som viser en ændring på 0.070% sammenlignet med året før. Ændringen i nettoindkomsten er 0.067%. Nettoindkomsten for det sidste år var 1055.34.

common:word.in-mln USD Growth	TTM	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002	2000	1998	1996	1994
income-statement-row.row.total-revenue	11567.99	11418.1	10544.9	8942.6	7879.7	7210.7	6376.4	5551.8	4772.2	4337.9	4232.8	3899.8	3480.1	1534.5	1521	1367.9	1250.4	1041.5	1148.6	1035.4	830.5	770.3	659.3	141.8	178.8	225.6	418.1	367.7	368.7	344.3	331.2
income-statement-row.row.cost-of-revenue	8770.97	8686.6	8024.2	6569.3	5676.6	4876.6	4340.5	3839.9	3444.3	3149.7	3131.4	3017	2672.7	1236.9	1201.1	1068.9	1011.5	845.8	915.4	833.4	671.4	611.2	511	130.7	156.6	187.1	366.3	313.1	313.6	294.6	288
income-statement-row.row.gross-profit	2797.01	2731.5	2520.7	2373.3	2203	2334.1	2035.9	1711.9	1327.9	1188.2	1101.4	882.8	807.4	297.6	319.9	298.9	238.9	195.7	233.1	202	159.1	159	148.3	11.1	22.3	38.5	51.8	54.6	55	49.7	43.1
income-statement-row.row.gross-profit-ratio	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.research-development	557.97	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-general-administrative	64.05	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-and-marketing-expenses	676.22	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-expenses	-39.69	-42	313.2	264.7	216.9	269.6	-30.8	3.9	74.4	66.8	28.7	22.7	27.1	16.1	7.2	3.9	1.2	6.6	2.5	1.7	1.5	0.7	2.4	7.5	16.7	13.9	19.8	7.1	5.8	6.4	4.1
income-statement-row.row.operating-expenses	1686	1649.4	1456.1	1287.3	1251.2	1608.4	1516.6	1255.7	1015.5	913.4	744.9	634.9	550.1	252.7	250.4	218	173.5	132.6	139.1	125.2	90.2	90.5	78.5	32.7	36	39.8	35.4	29.4	35.8	33.5	31.3
income-statement-row.row.cost-and-expenses	10456.97	10336	9480.3	7856.7	6927.9	6484.9	5857.1	5095.6	4459.8	4063.1	3876.3	3651.9	3222.9	1489.6	1451.5	1286.9	1185	978.5	1054.6	958.6	761.6	701.8	589.5	163.4	192.5	226.9	401.7	342.5	349.4	328.1	319.4
income-statement-row.row.interest-income	-22.64	113.6	75.8	75.3	24.9	7.3	5.4	4.2	8.9	12.2	19.3	17.2	11.2	3.6	2.9	4.8	6.8	3.2	4	1.3	1	1.9	1.9	0.1	0.9	0	0	0	0	0	0
income-statement-row.row.interest-expense	34.1	47.2	59.2	35.7	16	30.2	42	62.1	62.3	66.1	80.2	82.1	107.6	40.4	37.7	36.2	34.8	37.6	33.7	23.7	17.8	13.5	16.4	8.6	6.3	2.8	1.6	0.8	5.1	4.4	2
income-statement-row.row.selling-and-marketing-expenses	676.22	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.total-other-income-expensenet	66.36	119.3	0.4	-5.3	-8.6	-10.4	-57.1	-116.5	22.9	-27.8	20.7	-42.2	-88.9	-41.1	-42.1	-43.2	-38	-31.8	-35.9	-28.4	-21.7	-19.7	-19.9	-11.9	4.2	-1.8	2.4	3.7	-5.1	-4.5	-2.2
income-statement-row.row.ebitda-ratio-caps	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-operating-expenses	-39.69	-42	313.2	264.7	216.9	269.6	-30.8	3.9	74.4	66.8	28.7	22.7	27.1	16.1	7.2	3.9	1.2	6.6	2.5	1.7	1.5	0.7	2.4	7.5	16.7	13.9	19.8	7.1	5.8	6.4	4.1
income-statement-row.row.total-operating-expenses	66.36	119.3	0.4	-5.3	-8.6	-10.4	-57.1	-116.5	22.9	-27.8	20.7	-42.2	-88.9	-41.1	-42.1	-43.2	-38	-31.8	-35.9	-28.4	-21.7	-19.7	-19.9	-11.9	4.2	-1.8	2.4	3.7	-5.1	-4.5	-2.2
income-statement-row.row.interest-expense	34.1	47.2	59.2	35.7	16	30.2	42	62.1	62.3	66.1	80.2	82.1	107.6	40.4	37.7	36.2	34.8	37.6	33.7	23.7	17.8	13.5	16.4	8.6	6.3	2.8	1.6	0.8	5.1	4.4	2
income-statement-row.row.depreciation-and-amortization	238.89	559	548	460.3	338.9	407.6	329.4	331.6	302	286.2	247.8	227.5	193.3	100.5	90.1	82.3	66.4	52.4	53.1	44.4	37.7	33.5	27.3	4.1	6.1	6.1	4.5	-5.9	-0.7	-2.1	-2.3
income-statement-row.row.ebitda-caps	1379.21	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.operating-income	1140.32	1082.1	1011.6	1119.4	969.7	644.2	490.5	335.7	273.6	202.3	343.1	185.5	143.6	-11.4	21.2	34.6	26.7	25.4	61.4	52.9	48.6	50.7	49.9	-25	4.9	8.9	30.6	31.1	20	18.3	14.1
income-statement-row.row.income-before-tax	1206.68	1201.4	1012.1	1114.1	961.2	633.7	462.2	339.6	335.3	247	377.2	205.7	168.3	3.8	27.3	37.8	27.4	31.3	61	51.5	48.7	50.1	51.1	-25.5	6	9.9	34.6	33.5	20	18.2	13.9
income-statement-row.row.income-tax-expense	149.86	149.3	22.9	158.5	144.4	80.3	91.6	83	72.4	38.8	50.5	44.8	33.7	0.6	7.3	4.9	1.4	3.4	9.8	5.4	11.2	13.4	17.2	0.5	-1.5	2	8.5	10.5	5.7	5.2	3.4
income-statement-row.row.net-income	1059.75	1055.3	989.2	955.6	816.7	553.4	370.6	256.6	262.9	208.2	322.2	167.4	137.1	8.2	23.8	34.1	29.1	30.4	52	43.8	35.6	34.2	31.6	-25.9	7.5	7.6	25.7	23	14.2	13	10.6